Home / Pathology / Cellular Injury

Irreversible Cell Injury Indicators: Prognostic Indicators (Secondary Prevention Standard)

Cellular Injury Specialty Division
â–  LECTURE OVERVIEW: Cell injury progresses through a reversible stage before crossing a critical biochemical boundary into irreversible cell injury and cell death. â–  THE CROSSING SEGMENTS: 1. Calcium Accumulation: Depletion of intracellular ATP disables membrane-bound ATP-dependent calcium pumps (Ca2+-ATPase). Calcium rushes into the cytosol and the mitochondria. 2. Enzymatic Overdrive: Elevated cytosolic calcium activates multiple destructive cytosolic enzymes: phospholipases (peroxidizing membranes), proteases (degrading structural cytoskeleton), endonucleases (fragmenting chromatin), and ATPases (further depleting remaining ATP). 3. Heavy Mitochondrial Vacuolization: Mitochondria undergo profound swelling, accumulation of amorphous, calcium-rich dense bodies in the matrix, and permanent loss of membrane potential. 4. Lysosomal Rupture: Low intracellular pH destabilizes lysosomes, releasing acid hydrolases into the cytosol, which digest organelles from within. 5. Nuclear Destruction: Follows a specific sequence: Pyknosis (nuclear condensation), Karyorrhexis (nuclear fragmentation), and Karyolysis (enzymatic disintegration of DNA). â–  PROGNOSTIC CRITERIA & TIMELINE: Patient outcome scales correlate heavily with diagnostic staging at presentation, age, pre-existing comorbidities, and biological markers of cellular dividing rates. â–  SECONDARY PREVENTION METRICS: Implementing long-term dietary adaptations, physical therapy, and compliance aids reduces the rate of recurring acute crises by more than half. [HY-BOARD-1229]

🌟 Dynamic Clinical Key:

The loss of cell membrane permeability is the single most reliable indicator of irreversible injury. This allow tissue-specific intracellular enzymes to leak into systemic circulation where they serve as diagnostic biomarkers: e.g., Cardiac Troponin-I in myocardial infarction, or amylase/lipase in acute pancreatitis. Regularly reassess clinical parameters to adjust long-term therapy. Patient education regarding warning signs and therapy adherence is the cornerstone of secondary prevention.

Professional Medical Reference Application v2.5

For training, board examinations (USMLE, PLAB), and clinician benchmarking. Do not replace professional care.